Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stromal Cells for COVID-19
NCT04467047Phase 1Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Mesenchymal Stem Cells
01
Overview
Phase 1, open-label trial of Provacel in coronavirus disease 2019 (COVID-19), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Overall Survival at 60 days. Status: unknown.
02
Drugs
Provacel
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04467047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467047.